Literature DB >> 6992565

Genetic markers in human bone marrow transplantation.

K G Blume, E Beutler, K J Bross, G M Schmidt, W E Spruce, R L Teplitz.   

Abstract

Blood cell isozymes, red cell antigens, immunoglobulin allotypes, and marker chromosomes are suitable tools to monitor bone marrow engraftment and marrow graft quality. Data on genetic markers from 26 patients who underwent bone marrow transplantation as a treatment for acute leukemia are presented here.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6992565      PMCID: PMC1686065     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Staining of the A antigen human erythrocytes.

Authors:  D Y Mason; C R Taylor
Journal:  J Clin Pathol       Date:  1975-07       Impact factor: 3.411

Review 2.  Immunoreconstitution.

Authors:  R H Buckley
Journal:  Pediatr Clin North Am       Date:  1977-05       Impact factor: 3.278

3.  Immunologic reconstitution in severe combined immunodeficiency wihout bone-marrow chromosomal chimerism.

Authors:  E R Stiehm; G J Lawlor; M S Kaplan; H L Greenwald; R C Neerhout; D P Sengar; P I Terasaki
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

4.  Leukaemic transformation of engrafted human marrow cells in vivo.

Authors:  E D Thomas; J I Bryant; C D Buckner; R A Clift; A Fefer; F L Johnson; P Neiman; R E Ramberg; R Storb
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

5.  Leukaemic transformation of engrafted human marrow cells in vivo.

Authors:  P J Fialkow; E D Thomas; J I Bryant; P E Neiman
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

6.  Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies.

Authors:  L L Sensenbrenner; A A Steele; G W Santos
Journal:  Exp Hematol       Date:  1977-01       Impact factor: 3.084

7.  Recovery from aplastic anemia following attempted marrow transplantation.

Authors:  E D Thomas; R Storb; E R Giblett; B Longpre; P L Weiden; A Fefer; R Witherspoon; R A Clift; C D Buckner
Journal:  Exp Hematol       Date:  1976-03       Impact factor: 3.084

8.  Direct evidence for a bone marrow origin of the alveolar macrophage in man.

Authors:  E D Thomas; R E Ramberg; G E Sale; R S Sparkes; D W Golde
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

9.  Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia.

Authors:  B Speck; P Cornu; M Jeannet; C Nissen; H P Burri; P Groff; G A Nagel; C D Buckner
Journal:  Exp Hematol       Date:  1976-05       Impact factor: 3.084

10.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

View more
  5 in total

1.  Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation.

Authors:  H Hessel; J Mittermüller; H Zitzelsberger; H U Weier; M Bauchinger
Journal:  Histochem Cell Biol       Date:  1996-11       Impact factor: 4.304

2.  High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies.

Authors:  K G Blume; S J Forman
Journal:  Blut       Date:  1987-07

3.  Cytogenetic studies using Q-band polymorphisms in patients with AML receiving marrow from like-sex donors.

Authors:  M T Khokhar; S D Lawler; R L Powles; J L Millar
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

4.  Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms.

Authors:  D Ginsburg; J H Antin; B R Smith; S H Orkin; J M Rappeport
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Effects of mixed chimerism and immune modulation on GVHD, disease recurrence and survival after HLA-identical marrow transplantation for hematologic malignancies.

Authors:  S J Park; W S Min; I H Yang; H J Kim; C K Min; H S Eom; D W Kim; C W Han; J W Lee; C C Kim
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.